Prognostic value of the preoperative C-reactive protein-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma
PLOS One · 30.10.2026 · 21 (10) · e0362126
DOI: 10.1371/journal.pone.0362126 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, online erschienen am 30.10.2026. Verfasst von Minchao Qin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Jincheng People's Hospital, Jincheng, Shanxi Province, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, C-Reactive Protein, Kidney Neoplasms, Lymphocytes. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Changzhou Applied Basic Special Fund, incheng Key Research and Development Program.
Abstract (Originalsprache)
Background
Systemic inflammation is associated with the prognosis of clear cell renal cell carcinoma (ccRCC). The C-reactive protein-to-lymphocyte ratio (CLR) combines systemic inflammation and host immune status. However, its prognostic value in non-metastatic ccRCC remains unclear. This study evaluated the association between preoperative CLR and survival outcomes in patients with non-metastatic ccRCC.
Methods
We retrospectively included 414 patients with non-metastatic ccRCC who underwent partial or radical nephrectomy. The primary Cox analyses treated ln(CLR) as a continuous variable and assessed overall survival (OS) and the cause-specific hazard of ccRCC-related death. Sensitivity analyses included expanded adjustment and time-varying effects. Cut-off-based analyses were exploratory. Time-dependent receiver operating characteristic curves were used to compare CLR with other inflammatory markers. Incremental discrimination and calibration were assessed using bootstrap internal validation.
Results
After adjustment for age, Fuhrman grade, and T stage, ln(CLR) remained independently associated with OS (HR = 1.589, 95% CI 1.257–2.009; P < 0.001) and ccRCC-related death (HR = 1.612, 95% CI 1.266–2.052; P < 0.001). The associations persisted in sensitivity analyses addressing additional pathological factors and time-varying effects. The 3- and 5-year AUCs of CLR for OS were 0.810 and 0.776, respectively. No statistically significant AUC differences were detected between CLR and CRP, NLR, or CAR. Adding CLR increased the apparent C-index from 0.843 to 0.885. After bootstrap optimism correction, the C-indices were 0.832 and 0.873, respectively (ΔC-index = 0.041). Calibration was assessed at 3 and 5 years.
Conclusions
Preoperative CLR was independently associated with OS and the cause-specific hazard of ccRCC-related death in this single-center cohort. Adding CLR improved discrimination after internal validation, but its superiority over other inflammatory markers and clinical utility remain unestablished. Independent multicenter validation is needed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Urology, Jincheng People's Hospital, Jincheng, Shanxi Province, China.
- Department of Urology, Sir Run Run Hospital Nanjing Medical University, Nanjing, Jiangsu Province, China.
- Department of Urology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu Province, China.
ORCID-Profile: Zhen Chen
Förderung
- Changzhou Applied Basic Special Fund
- incheng Key Research and Development Program
Zitieren
APA
Qin, M., Feng, Z., Zhang, C., Song, W., Wang, K., & Chen, Z. (2026). Prognostic value of the preoperative C-reactive protein-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma. PLOS One, 21(10), e0362126. https://doi.org/10.1371/journal.pone.0362126
Vancouver
Qin M, Feng Z, Zhang C, Song W, Wang K, Chen Z. Prognostic value of the preoperative C-reactive protein-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma. PLOS One. 2026;21(10):e0362126. doi:10.1371/journal.pone.0362126
BibTeX
@article{Qin2026,
author = {Qin, Minchao and Feng, Zhongwen and Zhang, Chao and Song, Wei and Wang, Kai and Chen, Zhen},
title = {Prognostic value of the preoperative C-reactive protein-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma},
journal = {PLOS One},
year = {2026},
volume = {21},
number = {10},
pages = {e0362126},
doi = {10.1371/journal.pone.0362126}
}
EUVIMED